Glioblastoma Multiforme
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
20 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 38 trials with date data
Clinical Trials (39)
Total enrollment: 3,247 patients across 39 trials
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
UNITE Study: Understanding New Interventions With GBM ThErapy
Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
Pan Tumor Rollover Study
Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
AMG 102 and Avastin for Recurrent Malignant Glioma
Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)
Safety and Efficacy of Talampanel in Glioblastoma Multiforme
Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Multicenter Trial for Adults With Partial Seizures
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
NOA-12: BIBF1120 and R-RT in Glioblastoma
Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma
Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme
Effects of Talampanel on Patients With Advanced Parkinson's Disease
Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)
Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
Phase I Study of APX005M in Pediatric Central Nervous System Tumors
mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm
Gene Therapy for Pleural Malignancies
Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
Expanded Access for KHK2455
Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.